John T Schiller

4PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 03, 2025
In the activation of HPV-specific human B cells HPV-VLP vaccines mimic membrane-associated antigens.

Charles Torgbor, Haewon Sohn, Brian L P Dizon

|Apr 17, 2023
Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047.

Meredith S Shiels, Stanley Lipkowitz, Nicole G Campos

|Jan 09, 2023
HPV42, a "Low-Risk" Type, and Digital Papillary Adenocarcinoma.

Gabriel J Starrett, John T Schiller, Douglas R Lowy

|Mar 14, 2022
Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions.

Nathan R Fons, Rhonda C Kines, Cynthia D Thompson

Pageof 1